Previous 10 | Next 10 |
BRIDGEWATER, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , announced today it will participate in this year’s American Diabetes Association’s (ADA...
Armata Pharmaceuticals (NYSEMKT: ARMP ) +28% on encouraging AP-PA01 data . More news on: Armata Pharmaceuticals, Inc., Biocept, Inc., The9 Limited, Stocks on the move, Read more ...
BRIDGEWATER, N.J., May 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , today announced the inclusion by the American Diabetes Association (ADA) of the use of a “disp...
Gainers: Novan (NASDAQ: NOVN ) +27% . Sea Limited (NYSE: SE ) +23% . Allied Healthcare Products (NASDAQ: AHPI ) +17% . Westwater Resources (NASDAQ: WWR ) +12% . Novus Therapeutics (NASDAQ: NVUS ) +12% . Spherix Incorporated (NASDAQ: SPEX ) +11% . CSW Industrials (NASDAQ: CSWI )...
Valeritas Holdings (NASDAQ: VLRX ) +32% on positive V-Go data. More news on: Valeritas Holdings, Inc., Clean Energy Fuels Corp., Sea Limited, Stocks on the move, Read more ...
Thinly traded micro cap Valeritas Holdings (NASDAQ: VLRX ) is up 38% premarket on increased volume in reaction to new data from the VERDICT study, a real-world retrospective analysis of electronic medical records from a large diabetes center. More news on: Valeritas Holdings,...
BRIDGEWATER, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , today announced additional data from the VERDICT study at the International Society for Pharmacoecono...
BRIDGEWATER, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced th...
BRIDGEWATER, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced th...
Valeritas Holdings, Inc. (VLRX) Q1 2019 Earnings Conference Call May 9, 2019 04:30 PM ET Company Participants Greg Chodaczek - Investor Relations Erick Lucera - Chief Financial Officer John Timberlake - President and Chief Executive Officer Conference Call Participants Ste...
News, Short Squeeze, Breakout and More Instantly...
BRIDGEWATER, N.J. , Feb. 9, 2020 /PRNewswire/ -- Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , today announced an agreement to sell substantially all of the business to Z...
BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , today announced revised revenue guida...
BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...